Ingalls & Snyder LLC’s IRIDEX IRIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-25,015
Closed -$46K 429
2019
Q3
$46K Hold
25,015
﹤0.01% 415
2019
Q2
$114K Hold
25,015
0.01% 412
2019
Q1
$114K Hold
25,015
0.01% 401
2018
Q4
$118K Hold
25,015
0.01% 394
2018
Q3
$159K Hold
25,015
0.01% 423
2018
Q2
$174K Hold
25,015
0.01% 384
2018
Q1
$143K Hold
25,015
0.01% 380
2017
Q4
$191K Hold
25,015
0.01% 375
2017
Q3
$234K Buy
+25,015
New +$227K 0.01% 320

Other funds holding IRIX

Ingalls & Snyder LLC's IRIX Position: Q4 2019 in Review

Ingalls & Snyder LLC sold out of IRIDEX (IRIX) in Q4 2019, closing a stake of 25,015 shares — an estimated $46K sold.

Ingalls & Snyder LLC first reported a position in IRIX in Q3 2017 and held it in 9 quarters. The position peaked at $234K in Q3 2017. 26 funds tracked by Wall St. Rank hold IRIX as of Q4 2019.

  • Ingalls & Snyder LLC reported no remaining IRIDEX position as of Q4 2019 after selling out during the quarter.
  • Ingalls & Snyder LLC sold 25,015 IRIDEX shares in Q4 2019, an estimated $46K.
  • Ingalls & Snyder LLC first reported a position in IRIDEX in Q3 2017 and held it in 9 quarters.
  • Ingalls & Snyder LLC's IRIDEX position peaked at $234K in Q3 2017.
  • 26 funds tracked by Wall St. Rank held IRIDEX as of Q4 2019.

Based on Ingalls & Snyder LLC's 13F filing for Q4 2019, filed 15 Jan 2020.